438 related articles for article (PubMed ID: 9669266)
1. Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required? Yield of in-hospital monitoring and prediction of risk for significant arrhythmia complications.
Chung MK; Schweikert RA; Wilkoff BL; Niebauer MJ; Pinski SL; Trohman RG; Kidwell GA; Jaeger FJ; Morant VA; Miller DP; Tchou PJ
J Am Coll Cardiol; 1998 Jul; 32(1):169-76. PubMed ID: 9669266
[TBL] [Abstract][Full Text] [Related]
2. Risks of initiating therapy with sotalol for treatment of atrial fibrillation.
Marcus FI
J Am Coll Cardiol; 1998 Jul; 32(1):177-80. PubMed ID: 9669267
[No Abstract] [Full Text] [Related]
3. Adverse event rate during inpatient sotalol initiation for the management of supraventricular and ventricular tachycardia in the pediatric and young adult population.
Chandler SF; Chu E; Whitehill RD; Bevilacqua LM; Bezzerides VJ; DeWitt ES; Alexander ME; Abrams DJ; Triedman JK; Walsh EP; Mah DY
Heart Rhythm; 2020 Jun; 17(6):984-990. PubMed ID: 32014568
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and proarrhythmia of oral sotalol in pediatric patients.
Pfammatter JP; Paul T; Lehmann C; Kallfelz HC
J Am Coll Cardiol; 1995 Oct; 26(4):1002-7. PubMed ID: 7560592
[TBL] [Abstract][Full Text] [Related]
5. Risk prediction for adverse events during initiation of sotalol and dofetilide for the treatment of atrial fibrillation.
Agusala K; Oesterle A; Kulkarni C; Caprio T; Subacius H; Passman R
Pacing Clin Electrophysiol; 2015 Apr; 38(4):490-8. PubMed ID: 25626340
[TBL] [Abstract][Full Text] [Related]
6. Sotalol for atrial tachycardias after surgery for congenital heart disease.
Beaufort-Krol GC; Bink-Boelkens MT
Pacing Clin Electrophysiol; 1997 Aug; 20(8 Pt 2):2125-9. PubMed ID: 9272523
[TBL] [Abstract][Full Text] [Related]
7. [Results of oral sotalol therapy in children with supraventricular and ventricular arrhythmias].
Paul T; Lehmann C; Pfammatter JP; Kallfelz HC
Z Kardiol; 1994 Dec; 83(12):891-7. PubMed ID: 7531374
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.
Hohnloser SH; van de Loo A; Baedeker F
J Am Coll Cardiol; 1995 Oct; 26(4):852-8. PubMed ID: 7560608
[TBL] [Abstract][Full Text] [Related]
9. Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group.
Vos MA; Golitsyn SR; Stangl K; Ruda MY; Van Wijk LV; Harry JD; Perry KT; Touboul P; Steinbeck G; Wellens HJ
Heart; 1998 Jun; 79(6):568-75. PubMed ID: 10078083
[TBL] [Abstract][Full Text] [Related]
10. Multicenter Analysis of Dosing Protocols for Sotalol Initiation.
Biswas M; Levy A; Weber R; Tarakji K; Chung M; Noseworthy PA; Newton-Cheh C; Rosenberg MA
J Cardiovasc Pharmacol Ther; 2020 May; 25(3):212-218. PubMed ID: 31707834
[TBL] [Abstract][Full Text] [Related]
11. Safety and feasibility of a clinical pathway for the outpatient initiation of antiarrhythmic medications in patients with atrial fibrillation or atrial flutter.
Hauser TH; Pinto DS; Josephson ME; Zimetbaum P
Am J Cardiol; 2003 Jun; 91(12):1437-41. PubMed ID: 12804730
[TBL] [Abstract][Full Text] [Related]
12. Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports.
Faber TS; Zehender M; Van de Loo A; Hohnloser S; Just H
Clin Cardiol; 1994 Apr; 17(4):197-202. PubMed ID: 8187370
[TBL] [Abstract][Full Text] [Related]
13. Sotalol proarrhythmia: a report of five cases and an audit of the use of a sotalol in a teaching hospital.
Basta MN; Leitch JW; Fletcher PJ
Aust N Z J Med; 1996 Apr; 26(2):167-70. PubMed ID: 8744614
[TBL] [Abstract][Full Text] [Related]
14. A case series of sotalol-induced torsade de pointes in patients with atrial fibrillation--a tale with a twist.
Tan HH; Hsu LF; Kam RM; Chua T; Teo WS
Ann Acad Med Singap; 2003 May; 32(3):403-7. PubMed ID: 12854385
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and proarrhythmia with the use of d,l-sotalol for sustained ventricular tachyarrhythmias.
Kühlkamp V; Mermi J; Mewis C; Seipel L
J Cardiovasc Pharmacol; 1997 Mar; 29(3):373-81. PubMed ID: 9125676
[TBL] [Abstract][Full Text] [Related]
16. Results of sotalol (Darob) therapy in supraventricular tachyarrhythmias.
Toporan D; Protopopescu T; Ioan A; Paraschiv A
Rom J Intern Med; 1998; 36(3-4):207-17. PubMed ID: 10822517
[TBL] [Abstract][Full Text] [Related]
17. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
Joseph AP; Ward MR
Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228
[TBL] [Abstract][Full Text] [Related]
18. Sotalol in treatment of pediatric cardiac arrhythmias.
Celiker A; Ayabakan C; Ozer S; Ozme S
Pediatr Int; 2001 Dec; 43(6):624-30. PubMed ID: 11737739
[TBL] [Abstract][Full Text] [Related]
19. [The effectiveness and safety of d,l-sotalol in the ambulatory treatment of atrial fibrillation and flutter].
Cruz Cruz F; Iturralde Torres P; Picos Bovio E; Medeiros Domingo A; Infante Vázquez O
Arch Inst Cardiol Mex; 1998; 68(6):482-91. PubMed ID: 10365224
[TBL] [Abstract][Full Text] [Related]
20. Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group.
Sung RJ; Tan HL; Karagounis L; Hanyok JJ; Falk R; Platia E; Das G; Hardy SA
Am Heart J; 1995 Apr; 129(4):739-48. PubMed ID: 7900626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
